Summary of project PR001239
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001239. The data can be accessed directly via it's Project DOI: 10.21228/M8JT51 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Project ID: | PR001239 |
| Project DOI: | doi: 10.21228/M8JT51 |
| Project Title: | GLS2KO vs WT mouse hepatocytes |
| Project Type: | Genotype |
| Project Summary: | Test the effect of knocking out GLS2 in primary mouse heptocytes. This data set was generated by applying Mixed Mode chromatography coupled to a Q Exactive Plus Orbitrap Mass Spectrometer with enhanced MS resolution up to 280,000. The most significantly altered metabolites as identified by XCMS were used to test the ability of a Message Passing Neural Network (MPNN) Model to rank order metabolite IDs. |
| Institute: | Pfizer |
| Department: | Internal Medicine Research Unit, WRDM |
| Last Name: | Clasquin |
| First Name: | Michelle |
| Address: | 1 Portland St., Cambridge, MA 02139 |
| Email: | michelle.clasquin@pfizer.com |
| Phone: | 6174487289 |
| Contributors: | Gang Xing, Yuji Shi |
Summary of all studies in project PR001239
| Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
|---|---|---|---|---|---|---|---|---|
| ST001952 | GLS2KO vs WT mouse hepatocytes | Mus musculus | Pfizer | MS | 2021-11-08 | 1 | 6 | Uploaded data (138.6M)* |
